New Delhi, Jun 28 (UNI): Adar Poonawalla, chief executive of Covishield vaccine maker Serum Institute of India, on Monday said he has taken up at the highest level the problem faced by Indians inoculated with the vaccine entering Europe and hoped that the issue would be removed soon.
The European Union has come out with a Green Pass digital passport policy under which it does not recognise the Covishield vaccine, for post-vaccination travel to and from the 27-nation bloc.
“I realise that a lot of Indians who have taken COVISHIELD are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries, ” Poonawalla said in a tweet.
Media reports also said the Ministry of External Affairs has taken this up with the EU drug regulator, European Medicines Agency.
While Covishield has not been included in the list of vaccines for the Green Pass, the EMA has approved AstraZeneca manufactured vaccine Vaxzevria, along with Comirnaty (Pfizer/BioNTech), Moderna, Janssen (Johnson & Johnson).
Poonawalla also told a TV channel that SII has applied to the EMA for approval of Covishield in the European markets.
